Literature DB >> 3594481

The different effects of recombinant human tumor necrosis factor on rat fibrosarcoma sublines.

J Ishihara, N Saijo, Y Sasaki, H Nakano, A Ozaki, H Takahashi, M Sakurai, K Nakagawa, M Iigo, F Kanzawa.   

Abstract

The antitumor effect of recombinant human tumor necrosis factor (rH-TNF) on two clones of rat fibrosarcoma with different metastatic potential to lymph nodes was examined. The colony formation of clone A, which has high metastatic potential, was completely inhibited by continuous exposure to rH-TNF at 50 U/ml. In contrast, colony formation of clone G, which has low metastatic potential, was not inhibited by high concentrations of rH-TNF (10,000 U/ml). The inhibitory effect of rH-TNF on colony formation by clone A was also observed with a 1-h exposure to rH-TNF. This effect was time and concentration dependent, as determined by the colony assay, 3H-thymidine uptake assay, and 51Cr-release assay. 3H-thymidine and 3H-uridine uptake per cell of clone A exposed to rH-TNF was not decreased. This suggests that the mechanisms of the antitumor effect of rH-TNF were not due to inhibition of DNA and RNA synthesis of tumor cells. In vivo growth and lymph node metastases of clone A inoculated i.p. to Donryu strain rats were completely suppressed by 14 consecutive i.p. injections of 10(5) or 10(6) U/kg per day of rH-TNF. On the other hand the growth of clone G was not influenced by rH-TNF administration.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3594481     DOI: 10.1007/bf00205627

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  21 in total

1.  Stimulation of RNA synthesis in L-929 cells by rabbit tumor necrosis factor.

Authors:  J M Ostrove; G E Gifford
Journal:  Proc Soc Exp Biol Med       Date:  1979-03

2.  Possible requirement of internalization in the mechanism of in vitro cytotoxicity in tumor necrosis serum.

Authors:  F C Kull; P Cuatrecasas
Journal:  Cancer Res       Date:  1981-12       Impact factor: 12.701

3.  Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice.

Authors:  K Haranaka; N Satomi; A Sakurai
Journal:  Int J Cancer       Date:  1984-08-15       Impact factor: 7.396

4.  In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice.

Authors:  S Habu; H Fukui; K Shimamura; M Kasai; Y Nagai; K Okumura; N Tamaoki
Journal:  J Immunol       Date:  1981-07       Impact factor: 5.422

5.  Expression of metastatic potential of tumor cells in young nude mice is correlated with low levels of natural killer cell-mediated cytotoxicity.

Authors:  N Hanna
Journal:  Int J Cancer       Date:  1980-11-15       Impact factor: 7.396

6.  Tumor necrosis factor (TNF).

Authors:  L J Old
Journal:  Science       Date:  1985-11-08       Impact factor: 47.728

7.  Inhibition of experimental tumor metastasis by selective activation of natural killer cells.

Authors:  N Hanna
Journal:  Cancer Res       Date:  1982-04       Impact factor: 12.701

8.  Rabbit tumor necrosis factor: mechanism of action.

Authors:  M R Ruff; G E Gifford
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

9.  Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells.

Authors:  M Tsujimoto; Y K Yip; J Vilcek
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

10.  Role of natural killer cells in the destruction of circulating tumor emboli.

Authors:  N Hanna; I J Fidler
Journal:  J Natl Cancer Inst       Date:  1980-10       Impact factor: 13.506

View more
  1 in total

1.  In vitro antitumor effect of recombinant human tumor necrotizing factor on cultured human cancer cell lines and freshly isolated lung cancer cells by the human tumor clonogenic assay.

Authors:  Y Sasaki; F Kanzawa; H Takahashi; Y Matsushima; H Nakano; K Nakagawa; W S Hong; K Minato; Y Fujiwara; N Saijo
Journal:  Invest New Drugs       Date:  1987-12       Impact factor: 3.850

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.